Drug Discovery (ISSN: 2278-540X)
PublisherDiscovery Publication
ISSN-L2278-540X
ISSN2278-540X
E-ISSN2278-5396
IF(Impact Factor)2024 Evaluation Pending
Description
discoverypublication-AT-gmail.comDrug discovery journal is an international journal which broadly valued among pharmacy, medicine, biological and life scientists for its unique blend of important research papers, case studies, reviews, perspectives and news. Published monthly, the journal delivers exciting primary and advanced drug-discovery research from all areas of biology and medicine, from molecular biology to marketing of drugs, including;
Robotic drugs, Artificial drugs and Artificial gene-drug conjugates for eternal life and all kinds of diseases
Novel markers and targets
Novel perspectives on drug discovery pipeline
Novel therapeutic strategies (stem-cell therapy, vaccination, gene therapy, tissue modelling, tissue and non-tissue implants etc)
Novel technologies (diverse technological tools and techniques used for the discovery of new drug targets to launch new medicines)
Disease mechanisms (analysis of molecules, pathways, aetiology and pathogenesis of human disease)
High-throughput screening
Therapeutic targets (Drug targets)
Drug-transporters
Biomarkers-identification and analysis
Combinatorial chemistry, parallel synthesis, pharmacophore analysis and library design
Drug design
Drug delivery
ADME/Tox
Advances in key compound classes and therapeutic areas
Genes and Proteins
Artificial genes & peptides - its delivery & therapeutic activity
Genomics,Proteomics and Immunomics
Automation and technology
Medicinal chemistry and Virtual chemistry
Pharmacoinformatics, Druginformatics, Bioinformatics, Chemoinformatics and Immunoinformatics
Pharmaceutical chemistry
Pharmaceutical analysis
Pharmaceutics and Bio-pharmaceutics
Pharmacology, Clinical Pharmacology, Toxicology
Pharmacogenomics and Pharmacogenetics
Toxicogenomics and Toxicogenetics
Pharmacotherapy, Pharmaco-economics and Pharmaco-vigilance in drug discovery process
Immunology, Immunogenetics and Immuno-markers
Disease models (analysis of molecules, pathways, aetiology and pathogenesis of human disease)
Pre-clinical trials
Clinical trials (Phase I, II, III and IV)
Business and marketing strategy
Last modified: 2013-07-23 15:02:28
Volumes
- No Archives